Biotechnology Products
ORION has substantial experience in managing studies that involve complex, biologically-derived therapeutic agents.
This has included gene therapy products (‘naked’ DNA, lipid and viral vectors), monoclonal antibodies, genetically engineered proteins, therapeutic vaccines and many others.
We have conducted these studies in more than 20 countries and we are entirely familiar with the specific regulatory and ethics requirements associated with biotechnology products.
We also fully understand the practical aspects of running studies involving these products including maintaining the cold chain and can provide specific training for pharmacists and clinicians where necessary.